Sequenom, Inc. (Nasdaq: SQNM) announced the launch of the SensiGene Fetal RHD Genotyping test by Sequenom's CAP accredited and CLIA-certified ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE